Skip to main content

JAK/TYK2

      RT @Janetbirdope: Andrew Ostor @AbbVie symposium @eular_org presented HZ vaccines are safe in RA pts with #JAKi but with
      3 years 6 months ago
      Andrew Ostor @AbbVie symposium @eular_org presented HZ vaccines are safe in RA pts with #JAKi but with Recombinant HZ vaccine humeral response - 75% in RA pts in JAKi vs 100% controls. So should we hold JAKi with Shringix & if so for 1 or 2 wks? #EULAR2021 @RheumNow https://t.co/wVOFMa9fLm
      RT @Janetbirdope: Lifetime risk of HZ is 30%! ⬆️ in pts with immune diseases or immunesuppression. All #JAKI ⬆️
      3 years 6 months ago
      Lifetime risk of HZ is 30%! ⬆️ in pts with immune diseases or immunesuppression. All #JAKI ⬆️ risk maybe doubling but NNH & NNT give context. UPA Rx in active RA -20 more pts in remission vs 1 excess HZ if comparing UPA to ADA in RA @RheumNow #EULAR2021 AbbVie symposium https://t.co/14i0IsIpzs
      RT @Janetbirdope: Do you think JAKi cause VTE? @eular_org @RheumNow #EULAR2021
      3 years 6 months ago

      Do you think JAKi cause VTE? @eular_org @RheumNow #EULAR2021

      RT @Janetbirdope: Do you think #JAKI ⬆️ #MACE cardiovascular events vs TNFi? @eular_org @RheumNow #EULAR2021
      3 years 6 months ago

      Do you think #JAKI ⬆️ #MACE cardiovascular events vs TNFi? @eular_org @RheumNow #EULAR2021

      ×